Topoisomerase inhibitors as anticancer agents: a patent update

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.8, 2013-08, pp. : 1033-1056

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 15, 2016-09 ,pp. : 1219-1229

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review

By Lavecchia Antonio Di Giovanni Carmen Novellino Ettore

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 405-425

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging DNA topoisomerase inhibitors as anticancer drugs

By Denny William A

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 105-133

Informa Healthcare

Access to resources Recommend Favorite